Journal of Biopharmaceutical Statistics · 2014 · 20 citations · 15 references
Public HealthBiostatisticsBayesian BiostatisticsBayesian Data AnalysisExperimental DesignBayesian Clinical TrialsBayesian Experimental DesignBayesian InferenceClinical TrialsRandomized Controlled TrialsStudy DesignBayesian Phase Ii TrialsClinical Trial Design Under Bayesian FrameworkComparative Clinical TrialsPhase Ii Clinical TrialsRandomized Clinical TrialsRandomized ExperimentsSample Size CalculationSingle-arm Trials
Single-arm studies are typically used in phase II of clinical trials, whose main objective is to determine whether a new treatment warrants further testing in a randomized phase III trial. The introduction of randomization in phase II, to avoid the limits of studies based on historical controls, is a critical issue widely debated in the recent literature. We use a Bayesian approach to compare single-arm and randomized studies, based on a binary response variable, in terms of their abilities of reaching the correct decision about the new treatment, both when it performs better than the standard one and when it is less effective. We evaluate how the historical control rate, the total sample size, and the elicitation of the prior distributions affect the decision about which study performs better.
15
R: A Language and Environment for Statistical Computing
R Core Team · 2000 · 353K citations · Full text
Natural Sciences, Computer Science, Statistical Computing +10
Optimal two-stage designs for phase II clinical trials
Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations
Assessment of futility in clinical trials
Steven Snapinn, Mon‐Gy Chen, Qi Jiang et al. · Pharmaceutical Statistics · 2006 · 145 citations